These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20812144)

  • 21. Is allostery an intrinsic property of all dynamic proteins?
    Gunasekaran K; Ma B; Nussinov R
    Proteins; 2004 Nov; 57(3):433-43. PubMed ID: 15382234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
    Blacklock K; Verkhivker GM
    J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces.
    Zerbe BS; Hall DR; Vajda S; Whitty A; Kozakov D
    J Chem Inf Model; 2012 Aug; 52(8):2236-44. PubMed ID: 22770357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing Molecular Spanners to Throw in the Protein Networks.
    Serapian SA; Colombo G
    Chemistry; 2020 Apr; 26(21):4656-4670. PubMed ID: 31746512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Recognition of Unrelated Ligands by Identical Proteins.
    Pottel J; Levit A; Korczynska M; Fischer M; Shoichet BK
    ACS Chem Biol; 2018 Sep; 13(9):2522-2533. PubMed ID: 30095890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unbiased binding assays for discovering small-molecule probes and drugs.
    Kemp MM; Weïwer M; Koehler AN
    Bioorg Med Chem; 2012 Mar; 20(6):1979-89. PubMed ID: 22230199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular recognition and drug-lead identification: what can molecular simulations tell us?
    Morra G; Genoni A; Neves MA; Merz KM; Colombo G
    Curr Med Chem; 2010; 17(1):25-41. PubMed ID: 19941480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of conformational selection driving the formation of ligand binding sites in protein-protein interfaces.
    Bohnuud T; Kozakov D; Vajda S
    PLoS Comput Biol; 2014 Oct; 10(10):e1003872. PubMed ID: 25275445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allostery and population shift in drug discovery.
    Kar G; Keskin O; Gursoy A; Nussinov R
    Curr Opin Pharmacol; 2010 Dec; 10(6):715-22. PubMed ID: 20884293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding.
    Gunasekaran K; Nussinov R
    J Mol Biol; 2007 Jan; 365(1):257-73. PubMed ID: 17059826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
    Roughley SD; Hubbard RE
    J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
    [No Abstract]   [Full Text] [Related]  

  • 33. In Silico Target Druggability Assessment: From Structural to Systemic Approaches.
    Trosset JY; Cavé C
    Methods Mol Biol; 2019; 1953():63-88. PubMed ID: 30912016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Search strategies and evaluation in protein-protein docking: principles, advances and challenges.
    Huang SY
    Drug Discov Today; 2014 Aug; 19(8):1081-96. PubMed ID: 24594385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing biological mechanisms with chemical tools.
    Kang C; Keller TH
    Pharmacol Res; 2020 Mar; 153():104656. PubMed ID: 31962154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based computational analysis of protein binding sites for function and druggability prediction.
    Nisius B; Sha F; Gohlke H
    J Biotechnol; 2012 Jun; 159(3):123-34. PubMed ID: 22197384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.
    Laskowski RA; Swindells MB
    J Chem Inf Model; 2011 Oct; 51(10):2778-86. PubMed ID: 21919503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.